Brentuximab vedotin with chemotherapy for patients with previously untreated stage III/IV classical Hodgkin lymphoma: 5-year update of the ECHELON-1 study Meeting Abstract
| Authors: | Ramchandren, R.; Długosz-Danecka, M.; Connors, J. M.; Radford, J.; Illés, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; Walewski, J.; Zinzani, P. L.; Hutchings, M.; Munoz, J.; Kim, W. S.; Advani, R.; Ansell, S. M.; Gallamini, A.; Alekseev, S.; Lee, H. J.; Liu, R.; Little, M.; Fenton, K.; Fanale, M.; Straus, D. J. |
| Abstract Title: | Brentuximab vedotin with chemotherapy for patients with previously untreated stage III/IV classical Hodgkin lymphoma: 5-year update of the ECHELON-1 study |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | antibody-drug conjugate; brentuximab vedotin; chl; hl; echelon-1 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S371 |
| Language: | English |
| ACCESSION: | WOS:000691910500287 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(21)01849-8 |
| Notes: | Meeting Abstract: HL-147 -- Source: Wos |
